Bristol-Myers Squibb Co (BRM) Stock Price & News

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia

About Bristol-Myers Squibb Co

CEOChris Boerner

Employees၃.၂၅ သောင်း

Founded၁၈၈၇

Headquartersနယူးယောက်မြို့, နယူးယောက်ပြည်နယ်, ယူနိုက်တက်စတိတ်

Sector-

Websitebms.com

Revenue

Net income

All values in USD	၂၀၂၅ စက်	၂၀၂၅ ဒီ	၂၀၂၆ မတ်	၂၀၂၆ ဇွန်
Revenue	ဋေ ၁.၂၂ ထ	ဋေ ၁.၂၅ ထ	ဋေ ၁.၁၅ ထ	ဋေ ၁.၃၀ ထ
Cost of goods sold	၃၃၁.၂၀ ဋေ	၃၅၀.၇၀ ဋေ	၃၄၀.၈၀ ဋေ	၃၇၁.၁၀ ဋေ
Cost of revenue	၃၃၁.၂၀ ဋေ	၃၅၀.၇၀ ဋေ	၃၄၀.၈၀ ဋေ	၃၇၁.၁၀ ဋေ
Research and development expenses	၂၄၃.၃၀ ဋေ	၂၅၆.၁၀ ဋေ	၂၂၃.၈၀ ဋေ	၂၅၃.၆၀ ဋေ
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	၁၇၈.၈၀ ဋေ	၂၀၈.၇၀ ဋေ	၁၆၁.၀၀ ဋေ	၁၈၂.၄၀ ဋေ
Operating expense	၅၀၅.၂၀ ဋေ	၅၄၇.၄၀ ဋေ	၄၂၈.၅၀ ဋေ	၄၇၉.၇၀ ဋေ
Total operating expenses	၈၃၆.၄၀ ဋေ	၈၉၈.၁၀ ဋေ	၇၆၉.၃၀ ဋေ	၈၅၀.၈၀ ဋေ
Operating income	၃၈၅.၈၀ ဋေ	၃၅၂.၁၀ ဋေ	၃၇၉.၆၀ ဋေ	၄၄၆.၅၀ ဋေ
Other non operating income	၅၂.၉၀ ကုဋေ	၅၄.၄၀ ကုဋေ	၁၂.၅၀ ကုဋေ	၁၀.၆၀ ကုဋေ
EBT including unusual items	၃၁၁.၄၀ ဋေ	၁၄၇.၀၀ ဋေ	၃၂၃.၉၀ ဋေ	၄၀၈.၆၀ ဋေ
EBT excluding unusual items	၄၀၆.၇၀ ဋေ	၃၈၆.၄၀ ဋေ	၃၆၅.၄၀ ဋေ	၄၃၄.၆၀ ဋေ
Income tax expense	၉၁.၉၀ ကုဋေ	၃၈.၄၀ ကုဋေ	၅၆.၁၀ ကုဋေ	၇၇.၀၀ ကုဋေ
Effective tax rate	၂၉.၅၁%	၂၆.၁၂%	၁၇.၃၂%	၁၈.၈၄%
Other operating expenses	-	-	-	-
Net income	၂၂၀.၁၀ ဋေ	၁၀၈.၇၀ ဋေ	၂၆၇.၇၀ ဋေ	၃၃၁.၇၀ ဋေ
Net profit margin	၁၈.၀၁%	၈.၆၉%	၂၃.၃၀%	၂၅.၅၇%
Earnings per share	၁.၆၃	၁.၂၆	၁.၅၈	၂.၀၄
Interest and investment income	၁၆.၁၀ ကုဋေ	၁၄.၈၀ ကုဋေ	၁၀.၄၀ ကုဋေ	၁၀.၁၀ ကုဋေ
Interest expense	-၄၈.၂၀ ကုဋေ	-၄၃.၂၀ ကုဋေ	-၄၀.၆၀ ကုဋေ	-၄၀.၃၀ ကုဋေ
Net interest expenses	-၃၂.၁၀ ကုဋေ	-၂၈.၄၀ ကုဋေ	-၃၀.၂၀ ကုဋေ	-၃၀.၂၀ ကုဋေ
Depreciation and amortization charges	-	-	-	-
EBITDA	၄၉၀.၈၀ ဋေ	၄၅၄.၅၀ ဋေ	၄၄၀.၇၀ ဋေ	၅၀၇.၆၀ ဋေ
Gain or loss from assets sale	-၉.၀၀ သန်း	-	-၃.၄၀ ကုဋေ	-၁၄.၂၀ ကုဋေ

Ask anything